Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Cell Therapy (2)
50 Articles Available
2
3
Can't find what you're looking for? Try our
advanced search
.
Stem Cells
Delivering Pluripotent Stems Cells Primed to Differentiate
PAO-04-22-R250-71
Mesenchymal Stem Cells
A Media Platform for Cost-Effective and Scalable 2D and 3D Bioreactor MSC Expansion
PAO-04-022-CL-05
Facility Acquisition
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
PR-M04-22-01
Strategic Partnership
Chimeric Partners With Be The Match BioTherapies® To Advance CHM 1101 (CLTX CAR T)
PR-M03-22-07
Mesenchymal Stem Cells
The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances
PAO-12-21-NI-01
Cell Therapy
Expanding Access to Cell Therapies with a Patient-Centric Focus
PAO-02-022-CL-12
Cell and Gene Therapy
Realizing the Promise of Cell and Gene Therapy with an Advanced Manufacturing Platform
PAO-01-22-R250-15
Facility Acquisition
Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
PR-M01-22-18
2021 Roundup: The Year of Cell and Gene Therapy
Cell Therapy
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis
PAO-09-21-CL-13
Cell and Gene Therapy
Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products
PAO-09-21-CL-07
Cell Therapy
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
PAO-09-21-CL-04
Cancer Research
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
PR-M06-21-018
Cell Therapy Manufacturing
Innovating Cell Therapy Manufacturing
PAO-04-22-R221-09
COVID-19 Therapeutics
Tevogen Bio Announces Partnership With BioCentriq to Enhance Tevogen’s Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19
PR-M03-21-002
Facility Design
Cell Therapy Facility Design Synopsis: Horizontal vs. Vertical
PAO-03-21-CL-02
Cell Therapy
Economically Viable, Same-Day Autologous Cell Therapies
PAO-01-21-CL-06
Cell Therapy
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
PAO-12-20-CL-01
Cell & Gene Logistics
Standardizing Best Practices for Transporting Cell and Gene Therapies
PAP-Q3-20-CL-013
Cell Therapy Capacity
Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs
PR-M09-20-NI-17
In Conversation
In Conversation: Novel Off-The-Shelf Targeted Cell Therapies
PAP-Q2-20-CL-021
Cell Therapies
A Personalized Cell Therapy Chain Management Platform
PAP-Q2-20-CL-032
Cell Therapy
CD34+ Cell Therapy in Clinical Trials
PAP-Q4-19-CL-012
Stem Cells
iPSCs: Moving from Drug Testing to Novel Cell Therapies
PAP-Q3-19-CL-030
«
2
3
»